Laparoscopic Gastric Plication versus Laparoscopic Mini-Gastric Bypass surgery in the treatment of morbid obesity

The safety and efficacy of Laparoscopic Gastric Plication versus Laparoscopic Mini-Gastric Bypass surgery in the treatment of morbid obesity

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013012712294N1

Enrollment

Registered

2013-02-13

Start date

2010-03-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity. Morbid obesity

Interventions

Intervention 1: Laparoscopic Gastric Plication. Intervention 2: Laparoscopic Mini-Gastric Bypass.

Treatment - Surgery

Laparoscopic Gastric Plication

Laparoscopic Mini-Gastric Bypass

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: morbid obesity ( BMI>40 kg/m2 or BMI>35kg/m2 with co-existing morbidities ); age 18 to 65; previous unsuccessful weight loss attempts Exclusion criteria: previous restrictive or malabsorptive procedure for obesity treatment; previous gastric surgery; history of anti-reflux surgery; pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Operative time. Timepoint: during surgery. Method of measurement: with a clock.;Length of hospitalization. Timepoint: after discharging. Method of measurement: days of hospitalization.;Percent of excess weight loss. Timepoint: 12 months follow-up. Method of measurement: weight.;Hypertension. Timepoint: 12 months follow-up. Method of measurement: clinical examination and non invasive blood pressure measurement.;Diabetes. Timepoint: 12-month follow-up. Method of measurement: FBS , HgA1c.;Hyperlipidemia. Timepoint: 12 months follow-up. Method of measurement: cholesterol level,triglyceride.;Gastroesophageal reflux disease. Timepoint: 12 months follow-up. Method of measurement: Asking the patient.;Menstrual cycle. Timepoint: 12 months follow-up. Method of measurement: asking the patient.;Degenerative joint disease. Timepoint: 12 months follow-up. Method of measurement: history taking and physical exams.;Sleep apnea. Timepoint: 12 months follow-up. Method of measurement: Asking the patient.;Depression. Timepoint: 12 months follow-up. Method of measurement: Beck Depression Inventory score.;Back pain. Timepoint: 12 months follow-up. Method of measurement: visual analogue scale.	—

Measure

Time frame

Operative time. Timepoint: during surgery. Method of measurement: with a clock.;Length of hospitalization. Timepoint: after discharging. Method of measurement: days of hospitalization.;Percent of excess weight loss. Timepoint: 12 months follow-up. Method of measurement: weight.;Hypertension. Timepoint: 12 months follow-up. Method of measurement: clinical examination and non invasive blood pressure measurement.;Diabetes. Timepoint: 12-month follow-up. Method of measurement: FBS , HgA1c.;Hyperlipidemia. Timepoint: 12 months follow-up. Method of measurement: cholesterol level,triglyceride.;Gastroesophageal reflux disease. Timepoint: 12 months follow-up. Method of measurement: Asking the patient.;Menstrual cycle. Timepoint: 12 months follow-up. Method of measurement: asking the patient.;Degenerative joint disease. Timepoint: 12 months follow-up. Method of measurement: history taking and physical exams.;Sleep apnea. Timepoint: 12 months follow-up. Method of measurement: Asking the patient.;Depression. Timepoint: 12 months follow-up. Method of measurement: Beck Depression Inventory score.;Back pain. Timepoint: 12 months follow-up. Method of measurement: visual analogue scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Talebpour

Laparoscopic ward, Sina Hospital, Hasanabad Sq., Imam Khomeini St.

mtaleb7155@gmail.com+98 21 7780 7967

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026